Nova Patents
AT367159T

Immune response modifier compounds for treatment of th2 mediated and related diseases

Abstract

SOME COMPOUNDS MODIFYING THE IMMUNE RESPONSE imidazoquinoline amines, imidazopyridine amines, amine CICLOALQUILIMIDAZOPIRIDINA merged into 6.7, and amines imidazoquinoline WITH BRIDGE IN 1.2 - are useful for the treatment of diseases mediated by TH2, WITH THE ADMINISTRATION A therapeutically effective amount of said compounds, to inhibit IMMUNE RESPONSE OF TH2 cytokine induction DELETE IL - 4 / IL - 5 and eosinophilia, AND IMPROVE IMMUNE RESPONSE OF TH1.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

33 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
2930196United States of AmericaP
4533197United States of AmericaP

Members33

Family members, oldest first
DocumentOfficeKind
CA2268957A1CanadaA1
WO9817279A1World Intellectual Property Organization (WIPO)A1
AU5164198AAustraliaA
NO991908D0NorwayD0
NO991908LNorwayL
EP0938315A1European Patent Office (EPO)A1
IL129319D0IsraelD0
US6039969AUnited States of AmericaA
HU9904665A2HungaryA2
HK1022422A1Hong Kong, ChinaA1
KR20000052657ARepublic of KoreaA
AU724042B2AustraliaB2
CZ9901420A3CzechiaA3
HU9904665A3HungaryA3
NZ335124ANew ZealandA
JP2001502699AJapanA
US6200592B1United States of AmericaB1
US2002041887A1United States of AmericaA1
US6610319B2United States of AmericaB2
US2003206868A1United States of AmericaA1
US6696076B2United States of AmericaB2
US2004242620A1United States of AmericaA1
CZ294563B6CzechiaB6
KR100518903B1Republic of KoreaB1
IL129319AIsraelA
EP0938315B1European Patent Office (EPO)B1
AT367159TThis recordAustriaT
DE69737935D1GermanyD1
ES2290969T3SpainT3
EP0938315B9European Patent Office (EPO)B9
DE69737935T2GermanyT2
CA2268957CCanadaC
JP4391592B2JapanB2